Infectious diseases are disorders caused by micro-organisms such as viruses, bacteria, fungi, and parasites. These diseases can be transmitted from one individual to another through either direct contact or indirect contact. Anti-infective drugs are used to kill (cidal) or stop the growth (static) of infectious agents.
Based on the target organism, anti-infective drugs can be categorized into antibacterial, antiviral, antifungal, and antiparasitic. Anti-infective drugs can act via host defense system or can directly target the causative agent. Infectious diseases such as bacterial infections, respiratory diseases, HPV, and HIV are gradually increasing worldwide.
For instance, based on the study of WHO global health observatory (GHO) data, it is estimated that in 2013 34-38 million people suffered from HIV infection worldwide. Infectious diseases increasingly threaten public health and contribute significantly to the rising costs of health care.
Infectious disease diagnostic tests help in detecting new pathogens and specific pathogens, monitoring response to therapy, assessing prognosis, and determining appropriate treatment. The report analysts forecast the global infectious disease diagnostic testing market to grow at a CAGR of 11.48% over the period 2014-2019.
Covered in this report:
The report covers the present scenario and growth prospects of the global infectious disease diagnostic testing market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of following product categories:
Based on the target organism, anti-infective drugs can be categorized into antibacterial, antiviral, antifungal, and antiparasitic. Anti-infective drugs can act via host defense system or can directly target the causative agent. Infectious diseases such as bacterial infections, respiratory diseases, HPV, and HIV are gradually increasing worldwide.
For instance, based on the study of WHO global health observatory (GHO) data, it is estimated that in 2013 34-38 million people suffered from HIV infection worldwide. Infectious diseases increasingly threaten public health and contribute significantly to the rising costs of health care.
Infectious disease diagnostic tests help in detecting new pathogens and specific pathogens, monitoring response to therapy, assessing prognosis, and determining appropriate treatment. The report analysts forecast the global infectious disease diagnostic testing market to grow at a CAGR of 11.48% over the period 2014-2019.
Covered in this report:
The report covers the present scenario and growth prospects of the global infectious disease diagnostic testing market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of following product categories:
- Molecular diagnostic test
- POC infectious disease diagnostics test
POC infectious disease diagnostics test is classified into the following based on application:
- Respiratory
- HIV
- HAIs
- Sexual health
- Tropical diseases
- Liver
For Request Sample Copy:
http://www.radiantinsights.com/research/global-infectious-disease-diagnostics-testing-market-2015-2019#tabs-4
Global Infectious Disease Diagnostic Testing Market has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers APAC, Europe, Latin America, MEA, and North America; it also covers the landscape of the global infectious disease diagnostic testing market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market
Key regions
http://www.radiantinsights.com/research/global-infectious-disease-diagnostics-testing-market-2015-2019#tabs-4
Global Infectious Disease Diagnostic Testing Market has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers APAC, Europe, Latin America, MEA, and North America; it also covers the landscape of the global infectious disease diagnostic testing market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market
Key regions
- Americas
- APAC
- EMEA
Key vendors
- Abbott Diagnostic
- Alere
- bioMerieux
- Diasorin
- Roche Diagnostic
Other prominent vendors
- Beckman Coulter
- Becton, Dickinson and Company (BD)
- Bio-Rad Laboratories
- Cavidi
- Cepheid
- Corgenix
- Diaxonhit
- Eiken Chemical
- EMD Millipore
- Epitope Diagnostic
- EUROIMMUN
- Gold Standard Diagnostics
- Hologic
- Immunetics
- InBios International
- J.Mitra
- Meridian Bioscience
- OraSure Technologies
- ORGENTEC Diagnostika
- Ortho Clinical Diagnostics
- QIAGEN
- Quidel
- Siemens Healthcare Diagnostics
- TECHLAB
- Thermo Fisher Scientific
- Trinity Biotech
Key Market driver
- Increase in prevalence of infectious diseases
- For a full, detailed list, view our report
Key Market challenge
- Emerging infectious diseases
- For a full, detailed list, view our report
Key market trend
- Advances in technology
- For a full, detailed list, view our report
Key questions answered in this report
- What will the market size be in 2019 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
No comments:
Post a Comment